Publications
676
Citations
18,480
Est. group size
~71
Recurring co-author estimate
Active years
47
Publishing since 1980
Typically publishes in teams of ~10 · 11% small-team papers (≤3 authors) · across 18 venues
- Bridging single cells to organs: Mesoscale modules as fundamental units of tissue function
Cell · 2025
- Now you see me; now you don’t
Science Translational Medicine · 2025
- Oncostreams organize peritumoral glioma infiltration
Nature Cancer · 2025
- The transformative potential of mRNA vaccines for glioblastoma and human cancer: technological advances and translation to clinical trials
Frontiers in Oncology · 2024
- Valproic acid targets IDH1 mutants through alteration of lipid metabolism
npj Metabolic Health and Disease · 2024
- Publisher Correction: Valproic acid targets IDH1 mutants through alteration of lipid metabolism
npj Metabolic Health and Disease · 2024
- Modeling collective cell behavior in cancer: Perspectives from an interdisciplinary conversation
Cell Systems · 2023
- De novo lipogenesis pathway is a vulnerability in IDH1 mutant glioma
bioRxiv (Cold Spring Harbor Laboratory) · 2023
- Supplementary Data from Antiglioma Immunological Memory in Response to Conditional Cytotoxic/Immune-Stimulatory Gene Therapy: Humoral and Cellular Immunity Lead to Tumor Regression
2023
- Supplementary Figures 1-4 from Engineering the Brain Tumor Microenvironment Enhances the Efficacy of Dendritic Cell Vaccination: Implications for Clinical Trial Design
2023
- Supplementary Methods from Temozolomide Does Not Impair Gene Therapy-Mediated Antitumor Immunity in Syngeneic Brain Tumor Models
2023
- Supplementary Figure Legends from Temozolomide Does Not Impair Gene Therapy-Mediated Antitumor Immunity in Syngeneic Brain Tumor Models
2023
- Supplementary Figure 7 from Temozolomide Does Not Impair Gene Therapy-Mediated Antitumor Immunity in Syngeneic Brain Tumor Models
2023
- Supplementary Figure 6 from Temozolomide Does Not Impair Gene Therapy-Mediated Antitumor Immunity in Syngeneic Brain Tumor Models
2023
- Supplementary Figure 3 from Temozolomide Does Not Impair Gene Therapy-Mediated Antitumor Immunity in Syngeneic Brain Tumor Models
2023
- Neuro-Oncology×64
- bioRxiv (Cold Spring Harbor Laboratory)×18
- Cancer Research×11
- Journal of Visualized Experiments×6
- Clinical Cancer Research×5
- María G. Castro
Medicine · University of Michigan
- David Altshuler
Medicine · University of Michigan
- Alejandro J. Nicola Candia
Medicine · University of Michigan
- Diana Thomas
Medicine · The Ohio State University
- Maria G. Castro
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile